Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
EWTX
EWTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EWTX News
Edgewise Grants Stock Options to New Employees
Mar 02 2026
PRnewswire
Edgewise Grants Stock Options to New Employees
Mar 02 2026
Newsfilter
Edgewise Therapeutics Reports Q4 Results with Significant Cash Reserves
Feb 26 2026
seekingalpha
ORBIMED Reduces Stake in Terns Pharmaceuticals
Feb 20 2026
Fool
ORBIMED Reduces Stake in Terns Pharmaceuticals
Feb 20 2026
NASDAQ.COM
Cormorant Increases MoonLake Stake Above 6%
Feb 18 2026
stocktwits
Analyst Reiterates Bullish Stance on Edgewise Stock
Feb 10 2026
Fool
Analyst Reiterates Bullish Stance on Edgewise
Feb 10 2026
NASDAQ.COM
iShares U.S. Pharmaceuticals ETF Declines 1.8% on Thursday
Jan 15 2026
NASDAQ.COM
Edgewise Therapeutics CEO to Present at 44th J.P. Morgan Healthcare Conference
Jan 06 2026
Newsfilter
Edgewise Grants 119,250 Stock Options to New Employees Under Inducement Plan
Jan 05 2026
Newsfilter
Foresite Capital Fully Exits Edgewise Therapeutics, Incurring $7.67 Million Loss
Dec 30 2025
NASDAQ.COM
Foresite Capital Exits Edgewise Therapeutics, Reduces Stake by $7.67 Million
Dec 29 2025
Fool
Foresite Capital Fully Exits Edgewise Therapeutics, Incurring $7.67 Million Loss
Dec 29 2025
Yahoo Finance
Galectin Secures $10M Credit Line, FDA Provides Guidance on Regulatory Pathway
Dec 26 2025
NASDAQ.COM
Edgewise Therapeutics Reports Positive Phase 2 Data, Shares Surge 26%
Dec 25 2025
Fool
Show More News
